Keisuke Sako
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study.
Journal: Lupus science & medicine
Published: March 24, 2026
Iatrogenic immunodeficiency-associated polymorphic lymphoproliferative disorder resulting in complete remission after tacrolimus withdrawal in systemic lupus erythematosus: a case report.
Journal: Modern rheumatology case reports
Published: January 21, 2026
Interstitial palladin expression is associated with increased risk of end-stage kidney disease and death in patients with biopsy-proven diabetic kidney disease.
Journal: Clinical and experimental nephrology
Published: December 30, 2025
d-Alanine Hydrochloride and d-Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability.
Journal: Chemistry & biodiversity
Published: September 27, 2025
CD45 + C1q + CCR8+ Cells as Emerging Indicators of Kidney Disease Severity and Progression Risk.
Journal: Nephrology (Carlton, Vic.)
Published: June 23, 2025
Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial.
Journal: PloS one
Published: May 20, 2025
d-Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial.
Journal: Chemistry & biodiversity
Published: March 16, 2025
Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling.
Journal: The Journal of pathology
Published: March 11, 2025
Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies.
Journal: Gastro hep advances
Published: December 28, 2024
Correction: Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.
Journal: Clinical and experimental nephrology
Published: December 03, 2024
Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.
Journal: Clinical and experimental nephrology
Published: August 16, 2024
Last Updated: 09/26/2026